Skip to main content
logo
TaiwanJ Pharmaceuticals Co., Ltd. (TPEX:6549)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
7.51
-0.01 (-0.13%)
Apr 1, 2026, 1:57 PM CST

TaiwanJ Pharmaceuticals Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
--22.7415.3622.06-
Revenue Growth (YoY)
--48.11%-30.38%--
Cost of Revenue
---75.28--
Gross Profit
--22.74-59.9222.06-
Selling, General & Admin
14.5115.6415.3812.9814.0514.4
Research & Development
10.6111.3113.9712.7417.7325.98
Operating Expenses
25.1226.9629.3536.4731.7840.38
Operating Income
-25.12-26.96-6.61-96.39-9.73-40.38
Interest Expense
-0.03-0.01-0.02-0.01-0.01-0.03
Interest & Investment Income
1.752.12.520.490.040.09
Currency Exchange Gain (Loss)
-1.972.530.333.29-0.62-0.51
Other Non Operating Income (Expenses)
0.01-0.010.16--1.63
EBT Excluding Unusual Items
-25.36-22.34-3.77-92.47-10.32-42.46
Pretax Income
-25.36-22.34-3.77-92.47-10.32-42.46
Income Tax Expense
--2.27-2.11-
Net Income
-25.36-22.34-6.05-92.47-12.42-42.46
Net Income to Common
-25.36-22.34-6.05-92.47-12.42-42.46
Shares Outstanding (Basic)
797775757571
Shares Outstanding (Diluted)
797775757571
Shares Change (YoY)
5.22%1.89%-0.03%6.07%2.98%
EPS (Basic)
-0.32-0.29-0.08-1.23-0.17-0.60
EPS (Diluted)
-0.32-0.29-0.08-1.23-0.17-0.60
Free Cash Flow
-22.44-22.62-2.26-22.3-10.05-41.28
Free Cash Flow Per Share
-0.28-0.30-0.03-0.30-0.13-0.58
Gross Margin
--100.00%-100.00%-
Operating Margin
---29.07%-627.77%-44.09%-
Profit Margin
---26.59%-602.20%-56.32%-
Free Cash Flow Margin
---9.95%-145.22%-45.56%-
EBITDA
-24.13-25.76-5.29-20.49-9.12-39.67
EBITDA Margin
---23.28%-133.41%-41.37%-
D&A For EBITDA
0.991.191.3275.910.60.7
EBIT
-25.12-26.96-6.61-96.39-9.73-40.38
EBIT Margin
---29.07%--44.09%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.